Company profile
CYBERDYNE
CYBERDYNE develops wearable cyborg and rehabilitation technologies built around its HAL system. HAL detects bioelectric signals from the wearer and assists...
Facts
- Segment
- HEALTHCARE
- Country
- Japan
- Headquarters
- Tsukuba
- Founded
- 2004
- Ticker
- 7779
- Website
- https://www.cyberdyne.jp/english
About CYBERDYNE
CYBERDYNE develops wearable cybernic systems centred on the HAL platform. HAL detects bioelectrical signals associated with a user's intended movement and controls powered joints to assist motion, linking human neural intent with robotic actuation.
Medical and rehabilitation configurations support repeated movement training, while non-medical versions assist mobility or physical work. The company also operates treatment and service programmes around the hardware. Each HAL model has defined users, supervision requirements and regulatory status, and is fitted and deployed through approved clinical or workplace channels.
Market context
DEPLOYMENT
Summary
Type: Exoskeletons
Core: HAL
Function: Rehab
Audience: Healthcare
Research, Articles and recent verified events
- CYBERDYNE and Pegasus launch JPY 10B Physical AI CVC fund — 2026-06-16
- CYBERDYNE signs strategic MoU with Carnegie Mellon University — 2026-01-21
- CYBERDYNE and Thailand's Institute of Geriatric Medicine agree ASEAN healthcare innovation MoU — 2026-01-14
- HAL study on neuroplasticity and therapeutic benefit is published in an international medical journal — 2025-06-26
- CYBERDYNE signs MoU with National Taiwan University and the University of Tsukuba — 2025-06-18
- CYBERDYNE obtains Japanese approval for small-size model of Medical HAL — 2025-01-31
- CYBERDYNE launches Medical Vital Sensor Cyvis M100 with Japan medical-device clearance and insurance coverage — 2024-12-10